Edition:
United States

BioScrip Inc (BIOS.O)

BIOS.O on Nasdaq

2.98USD
19 Jul 2017
Change (% chg)

-- (--)
Prev Close
$2.98
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,458,589
52-wk High
$3.43
52-wk Low
$0.98

BIOS.O

Chart for BIOS.O

About

BioScrip, Inc. is engaged in providing infusion solutions. The Company partners with physicians, hospital systems, skilled nursing facilities, healthcare payors and pharmaceutical manufacturers to provide patients access to post-acute care services. The Company operates through Infusion Services segment. The Company operates... (more)

Overall

Beta: 0.39
Market Cap(Mil.): $360.53
Shares Outstanding(Mil.): 120.98
Dividend: --
Yield (%): --

Financials

  BIOS.O Industry Sector
P/E (TTM): -- 30.41 15.69
EPS (TTM): -0.50 -- --
ROI: -10.27 7.25 -8.21
ROE: -- 11.61 -7.82

BRIEF-Ares Management reports 9.2 pct stake in Bioscrip

* Ares Management reports 9.2 pct stake in Bioscrip as of June 29 - SEC filing

Jul 10 2017

BRIEF-BioScrip announces new senior note facilities

* BioScrip Inc - under agreement, company entered into a $200 million first lien note facility and a $110 million second lien note facility

Jun 29 2017

BRIEF-Bioscrip provides update on Unitedhealthcare contract

* Bioscrip Inc - ‍reached an agreement to continue to provide certain core product lines to unitedhealthcare beyond September 30, 2017​

May 30 2017

BRIEF-Bioscrip reports first quarter 2017 financial results

* Q1 revenue $217.8 million versus I/B/E/S view $229.7 million

May 04 2017

BRIEF-Bioscrip Q4 loss per share $0.06

* Bioscrip reports fourth quarter and full-year 2016 financial results

Mar 03 2017

Earnings vs. Estimates